Cargando…
Role of posaconazole in the management of oropharyngeal and esophageal candidiasis
Mucocutaneous candidiasis (MC) is one of the first signs of human immunodeficiency virus (HIV) infection. Over 90% of patients with AIDS will eventually develop oropharyngeal candidiasis (OPC) at some time during their illness, and an additional 10% will develop esophageal candidiasis (EC). Although...
Autor principal: | Vazquez, Jose A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374940/ https://www.ncbi.nlm.nih.gov/pubmed/18472974 |
Ejemplares similares
-
Role of posaconazole in the treatment of oropharyngeal candidiasis
por: Ianas, Voichita, et al.
Publicado: (2010) -
Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection
por: Vazquez, Jose A
Publicado: (2010) -
Esophageal Stricture in a child with Recurrent Oropharyngeal Candidiasis With Pseudomonas aeruginosa Esophagitis
por: Chakravarty, Naina, et al.
Publicado: (2020) -
Rethinking T cell immunity in oropharyngeal candidiasis
por: Pirofski, Liise-anne, et al.
Publicado: (2009) -
Management of oropharyngeal candidiasis with localized oral miconazole therapy: efficacy, safety, and patient acceptability
por: Collins, Curtis D, et al.
Publicado: (2011)